Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Efficient co-crystal screening using solution-mediated phase transformation.

Geoff G Z Zhang, Rodger F Henry, Thomas B Borchardt

    Journal of Pharmaceutical Sciences
    |April 25, 2007
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Non-destructive pipeline for analysis of crystalline solid dispersions.

    International journal of pharmaceutics·2026
    Same author

    Discovery of Fosigotifator, a Potent eIF2B Activator with Desired Properties for Human Studies.

    Journal of medicinal chemistry·2026
    Same author

    Exploring Digestion-Induced Fed-State Simulated Intestinal Media with a Lipid Fraction and Compositional Variability.

    The AAPS journal·2026
    Same author

    Investigating the Relationship between In Vitro and In Vivo Performance: The Role of Drug Loading, Release Rate, and Surface Area.

    Molecular pharmaceutics·2026
    Same author

    Hydrogen Bonding as a Failure Mechanism for Release of Ibuprofen-Copovidone Amorphous Solid Dispersions.

    Molecular pharmaceutics·2026
    Same author

    2025 Top JPharmSci Reviewers.

    Journal of pharmaceutical sciences·2025
    Same journal

    Green, renewable, or low-carbon? A framework for informed solvent selection in pharmaceutical sciences.

    Journal of pharmaceutical sciences·2026
    Same journal

    Theranostic potential of ramucirumab functionalized magnetoliposomes for targeted delivery of sorafenib and MRI.

    Journal of pharmaceutical sciences·2026
    Same journal

    Intranasal mucoadhesive chitosan microspheres of ranolazine: Formulation, design, and pharmacokinetic evaluation.

    Journal of pharmaceutical sciences·2026
    Same journal

    Evolving landscape of drug development for pediatric rare diseases-from successes to strategies for addressing unmet needs.

    Journal of pharmaceutical sciences·2026
    Same journal

    A mathematical framework for predicting tablet weight variability from blend particle size distribution and tooling geometry.

    Journal of pharmaceutical sciences·2026
    Same journal

    Recrystallization can stop nitrosamine formation in ranitidine hydrochloride.

    Journal of pharmaceutical sciences·2026
    See all related articles

    A new physical stability treatment for pharmaceutical co-crystals has been developed. This method, along with a novel screening technique, successfully tested sixteen co-crystal systems, improving screening efficiency.

    Area of Science:

    • Solid-state chemistry and pharmaceutical science.

    Background:

    • Established physical stability treatments for hydrates/solvates are extended to co-crystals.
    • Co-crystallization is a key strategy for modifying pharmaceutical solid-state properties.

    Discussion:

    • A novel suspension/slurry screening technique is developed based on the extended physical stability treatment.
    • This technique was successfully validated across sixteen diverse pharmaceutical co-crystal systems.

    Key Insights:

    • The proposed theoretical treatment provides a framework for understanding co-crystal physical stability.
    • The practical screening technique enhances the efficiency of identifying stable co-crystal forms.

    Outlook:

    • This work offers valuable tools for researchers in pharmaceutical co-crystallization.

    Related Experiment Videos

  • Improved screening efficiency can accelerate drug development and formulation design.